Related Experiment Video
Updated: Aug 10, 2026

08:58
Fluorimetric Techniques for the Assessment of Sperm Membranes
Published on: November 28, 2018
VAMP/synaptobrevin as an acrosomal marker for human sperm
João Ramalho-Santos1, Yukihiro Terada, Gerald Schatten
1Oregon Health Sciences University, Beaverton , Oregon, USA. jramalho2ci.uc.pt
Fertility and Sterility
|January 10, 2002
Summary
Vehicle-associated membrane protein (VAMP)/synaptobrevin shows promise for detecting acrosome abnormalities in human sperm. This marker can identify defects, aiding in the functional assessment of sperm health for infertility evaluations.
Area of Science:
- Reproductive biology
- Spermatozoa research
- Cellular markers
Background:
- The acrosome is crucial for fertilization.
- Acrosomal abnormalities can cause male infertility.
- Reliable markers for acrosomal status are needed.
Purpose of the Study:
- To investigate the utility of vehicle-associated membrane protein (VAMP)/synaptobrevin as a marker for human sperm acrosome abnormalities.
- To assess the correlation between VAMP staining patterns and known acrosomal defects.
Main Methods:
- Human sperm samples were obtained from patients in an infertility program.
- Sperm were fixed, permeabilized, and immunostained using an anti-VAMP antibody.
- Immunocytochemistry was employed to visualize VAMP localization within the acrosome.
Main Results:
- Normal VAMP staining was observed in sperm with morphologically normal acrosomes.
- Significant acrosome malformations, including absence of the organelle, were detected in patients with globozoospermia.
- Abnormal VAMP staining patterns correlated with identified acrosomal defects.
Conclusions:
- Vehicle-associated membrane protein (VAMP)/synaptobrevin serves as a potential marker for assessing acrosomal status in human sperm.
- VAMP immunostaining can aid in the functional evaluation of sperm and diagnosis of infertility causes.
- This marker may improve diagnostic capabilities for male factor infertility related to acrosomal dysfunction.

